We are live on ! Find out more
DSC

Duncker Streett & Co Portfolio holdings

AUM $526M
1-Year Est. Return 22.2%
This Fund
S&P 500
This Quarter Est. Return
+1.2%
1 Year Est. Return
+22.2%
3 Year Est. Return
+74.69%
5 Year Est. Return
+94.09%
10 Year Est. Return
+300.66%
AUM
$306M
AUM Growth
+$521K
Cap. Flow
-$965K
Cap. Flow %
-0.32%
Top 10 Hldgs %
17.83%
Holding
639
New
16
Increased
105
Reduced
115
Closed
12

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.12M
2
AGN
Allergan plc
AGN
+$845K
3
MDT icon
Medtronic
MDT
+$718K
4
WBA
Walgreens Boots Alliance
WBA
+$470K
5
MCK icon
McKesson
MCK
+$360K

Sector Composition

Rank Sector Weight
1 Healthcare 19.05%
2 Financials 10.75%
3 Industrials 10.72%
4 Technology 9.78%
5 Energy 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$631B
$9.97M 3.26%
117,356
-5,410
-4% -$480K
DHR icon
2
Danaher
DHR
$141B
$6.13M 2.01%
107,478
-818
-0.8% -$46.9K
MA icon
3
Mastercard
MA
$496B
$6.04M 1.98%
69,887
+1,282
+2% +$111K
AAPL icon
4
Apple
AAPL
$4.99T
$5.51M 1.8%
177,284
+37,244
+27% +$1.12M
TMO icon
5
Thermo Fisher Scientific
TMO
$214B
$5.2M 1.7%
38,682
-250
-0.6% -$32.2K
GE icon
6
GE Aerospace
GE
$376B
$4.87M 1.59%
40,940
-1,690
-4% -$201K
KMI icon
7
Kinder Morgan
KMI
$70.3B
$4.36M 1.43%
103,537
-1,480
-1% -$61.3K
PG icon
8
Procter & Gamble
PG
$352B
$4.33M 1.42%
52,841
-98
-0.2% -$8.43K
ECL icon
9
Ecolab
ECL
$78.9B
$4.04M 1.32%
35,289
+557
+2% +$61K
IBM icon
10
IBM
IBM
$212B
$4.03M 1.32%
26,246
-523
-2% -$79.3K
HSIC icon
11
Henry Schein
HSIC
$9.7B
$3.9M 1.28%
71,229
-204
-0.3% -$11.2K
AGN
12
DELISTED
Allergan plc
AGN
$3.89M 1.27%
13,064
+2,965
+29% +$845K
VFC icon
13
VF Corp
VFC
$6.93B
$3.73M 1.22%
52,659
+313
+0.6% +$21.7K
IGSB icon
14
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$3.51M 1.15%
66,530
+216
+0.3% +$11.4K
ITW icon
15
Illinois Tool Works
ITW
$85.8B
$3.44M 1.13%
35,391
-197
-0.6% -$19K
PFE icon
16
Pfizer
PFE
$143B
$3.42M 1.12%
103,607
+19
+0% +$604
CVS icon
17
CVS Health
CVS
$138B
$3.35M 1.1%
32,490
ABBV icon
18
AbbVie
ABBV
$468B
$3.29M 1.08%
56,236
+768
+1% +$46.4K
MRK icon
19
Merck
MRK
$325B
$3.2M 1.05%
58,333
-987
-2% -$55.9K
SYK icon
20
Stryker
SYK
$132B
$3.02M 0.99%
32,770
IGIB icon
21
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$3M 0.98%
54,258
+34
+0.1% +$1.87K
QCOM icon
22
Qualcomm
QCOM
$177B
$3M 0.98%
43,211
-623
-1% -$43.9K
JNJ icon
23
Johnson & Johnson
JNJ
$650B
$2.99M 0.98%
29,733
-245
-0.8% -$24.9K
NKE icon
24
Nike
NKE
$64B
$2.96M 0.97%
59,054
-700
-1% -$33.5K
CVX icon
25
Chevron
CVX
$373B
$2.96M 0.97%
28,186
-1,474
-5% -$157K

Similar funds

Duncker Streett & Co's Q1 2015 Portfolio in Review

As of Q1 2015, Duncker Streett & Co held 639 positions worth $306M, up 0.17% from $305M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q1 2015: portfolio turnover was 4.4%. Duncker Streett & Co opened 16 new positions and exited 12, leaving the 639-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Duncker Streett & Co's largest Q1 2015 buy was Chicago Bridge & Iron Nv: 4,300 shares worth $212K.
  • Duncker Streett & Co added most to Apple in Q1 2015, an estimated $1.12M increase.
  • Duncker Streett & Co's biggest Q1 2015 reduction was ExxonMobil, cutting an estimated $480K.
  • Duncker Streett & Co fully exited Allergan Inc in Q1 2015, selling an estimated $1.72M.
  • Duncker Streett & Co's ten largest holdings make up 18% of its $306M portfolio in Q1 2015.
  • Duncker Streett & Co opened 16 new positions and closed 12 in Q1 2015.
  • Duncker Streett & Co's portfolio value rose 0.17% quarter-over-quarter to $306M.

Based on Duncker Streett & Co's 13F filing for Q1 2015, filed 28 Apr 2015.